Silva, Monalisa Ribeiro <br/><br/>
Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions.  [electronic resource] 

 -  Pharmacology, biochemistry, and behavior  04 2018 
 - 17-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5177 
<br/><br/><label>Standard No.: </label>10.1016/j.pbb.2018.02.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dihydroxyphenylacetic Acid--metabolism<br/>Animals<br/>Brain--metabolism<br/>Brain Ischemia--prevention & control<br/>Cyclooxygenase 2 Inhibitors--pharmacology<br/>Dopamine--metabolism<br/>Dose-Response Relationship, Drug<br/>Glycogen Synthase Kinases--antagonists & inhibitors<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Lipid Peroxidation<br/>Male<br/>Neuroprotective Agents--pharmacology<br/>Nitric Oxide Synthase Type II--metabolism<br/>Nitrites--metabolism<br/>Rats<br/>Valproic Acid--pharmacology